This article proposes a simple and pragmatic classification of non-insulin glucose lowering drugs, which makes the pharmacology of diabetes easy to understand. While it is based on predominant mechanism of action, it encourages a pathophysiology-based approach to choice of drugs and drug combinations/permutations.